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Background: Autism spectrum disorder is a diagnosis that is increasingly applied; however, previous studies have
conflicting findings whether rates of diagnosis rates continue to grow in the UK. This study tested whether the
proportion of people receiving a new autism diagnosis has been increasing over a twenty-year period, both overall and
by subgroups. Method: Population-based study utilizing the Clinical Practice Research Datalink (CPRD) primary
care database, which contains patients registered with practices contributing data to the CPRD between 1998 and
2018 (N = 6,786,212 in 1998 to N = 9,594,598 in 2018). 65,665 patients had a diagnosis of autism recorded in
2018.Time trend of new (incident) cases of autism diagnosis was plotted for all, and stratified by gender, diagnostic
subtypes, and developmental stage: infancy and preschool, 0–5 years old; childhood, 6–11 years old; adolescence,
12–19 years old; adults, over 19 years old. Results: There was a 787%, exponential increase in recorded incidence of
autism diagnoses between 1998 and 2018; R2 = 0.98, exponentiated coefficient = 1.07, 95% CI [1.06, 1.08],
p < .001. The increase in diagnoses was greater for females than males (exponentiated interaction coefficient = 1.02,
95% CI [1.01, 1.03], p < .001) and moderated by age band, with the greatest rises in diagnostic incidence among
adults (exponentiated interaction coefficient = 1.06, 95% CI [1.04, 1.07], p < .001). Conclusions: Increases could be
due to growth in prevalence or, more likely, increased reporting and application of diagnosis. Rising diagnosis among
adults, females and higher functioning individuals suggest augmented recognition underpins these changes.
Keywords: Autism; autism spectrum disorder; diagnosis; primary care; clinical practice research datalink; time
trends.
Introduction
Much interest surrounds the rising use of the autism
spectrum disorder diagnosis, the various forms of
which we refer to as ‘autism’. Several studies in both
the United States and Europe report increasing
application of this diagnosis over the last twenty
years, but have measured autism in different ways,
limiting comparability (Boyle et al., 2011; Keyes
et al., 2012; Maenner & Durkin, 2010; Parner,
Schendel, & Thorsen, 2008; Smeeth et al., 2004).
In contrast, Taylor et al. found the incidence of
recorded autism at age eight remained stable across
a six-year period in the UK, in data from the General
Practice Research Database (GPRD; Taylor, Jick, &
MacLaughlin, 2013). Previous US studies have
shown how diagnostic substitution (Shattuck,
2006), increased awareness, and expansion of the
spectrum to include high functioning and cognitively
able individuals (Keyes et al., 2012) have led to
increased diagnosis of autism. A Swedish study
found that levels of autism symptoms were constant
in the population over a ten-year period, in contrast
to large increases in recorded diagnoses in the
Swedish patient register (Lundstr€om, Reichenberg,
Anckars€ater, Lichtenstein, & Gillberg, 2015). As time
passed, noticeably fewer autism symptoms seemed
to be required for a clinical diagnosis of autism
(Arvidsson, Gillberg, Lichtenstein, & Lundstr€om,
2018). More diagnoses were made with time, despite
no parallel increase in autistic symptoms in the
population, because autism symptom thresholds for
diagnosis had dropped (Arvidsson et al., 2018;
Lundstr€om et al., 2015).
The current study aims to establish the time trend
in new (incident) autism diagnosis in the UK over a
period of twenty years (1998–2018). The UK National
Health Service (NHS) is a publicly funded health
service, free at the point of use. General practitioners
(GPs) are the ‘gatekeepers’ of the NHS, referring
patients to secondary care. Over 98% of the popula-
tion is registered at one of the 7,300 GP practices, all
of which routinely code diagnostic data into the
Clinical Practice Research Datalink (CPRD, formerly
GPRD). We expand the previous GPRD study (Taylor
et al., 2013) by calculating incidence applying a
much longer timeframe, with an examination of new
autism diagnoses by multiple developmental stages,
gender, and diagnostic subtypes.
This study is, to our knowledge, the first to
establish trends of diagnosis across developmental
stages, which are of particular interest for policy and
commissioning reasons. During the last twenty
years, there has been a strong policy directive to
provide earlier recognition and diagnosis of autism,*Deceased.
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in other words to diagnose children at younger ages
(Fernell, Eriksson, & Gillberg, 2013; Landa, 2008;
Teitelbaum, Teitelbaum, Nye, Fryman, & Maurer,
1998). Additionally, the Autism Act of 2009 in the UK
made provision of adult autism diagnostic services a
statutory duty of local authorities (Autism Act, 2009),
a response to the campaign championed by the
National Autistic Society. The resulting UK network
of adult autism diagnostic services should have had a
dramatic impact on rates of diagnosis in this age-
group. In 2009, less than 50% of local authorities in
England had adult diagnosis services, compared with
almost all (93%) by 2019 (NAS, 2019). Time trends
within developmental life stages can prove any
impact of such policy directives. There has also been
mounting research and policy interest in possible
under-recognition and under-diagnosis of girls and
women with autism (Loomes, Hull, & Mandy, 2017).
Ten years ago, a UK study found that, even with
severity of autistic traits held constant, boys were
more likely to receive a diagnosis than girls (Russell,
Steer, & Golding, 2011), while work from the United
States has highlighted possible gender bias in the
identification of children with special educational
needs more broadly (Arms, Bickett, & Graf, 2008).
Such research attention has contributed with stories
in UK media about females missing out on diagnosis
(Russell, 2020), broadcasting a message that diag-
nosing females with autism is a priority. Comparing
rising rates of diagnosis in males versus females over
time is therefore of interest.
Pathways to diagnosis
In the UK, autism diagnoses are made in specialized
health services, known as ‘secondary care’, and not
by GPs. GPs will refer a suspected case onto
secondary care where autism is normally assessed
by a multidisciplinary team. Referrals may also come
directly from young people, families, schools, and
social workers. The secondary care service for adults
is in specialist autism or neurodevelopmental ser-
vices, or, for those younger than 19 years old, at
Child and Adolescent Mental Health Services
(CAMHs), or a specialist neurodevelopmental or
autism service. Younger, preschool children are
most often diagnosed by community pediatric teams.
In other words, there are several routes to diagnosis,
but all flow through secondary care. There is a risk
that information about diagnoses may not be passed
from secondary to primary care (pediatricians or
CAMHs to GP sources), not be communicated, as
parents may not approve sharing with GP, or be
incorrectly recorded. The pathways above relate to
the National Health Service, which is free at the point
of delivery but suffers from long waiting lists, leading
some families to seek assessment from private
practitioners. Diagnoses made by private services
are not routinely fed back to GPs, instead clients
(parents or adults) are provided the diagnosis by
private companies to use as they will. This means
that the CPRD is likely to underreport autism
diagnoses. The study objectives were not, therefore,
to give point prevalence estimates but to (a) assess
the overall time trend in new autism diagnosis rates
and (b) examine said trends by developmental stage,
gender, and diagnostic subtype to assess the broad
impact of policy on diagnostic rates. Our main
hypothesis was that the incidence of recorded




CPRD Aurum is a database containing routinely collected data
from 738 GP practices in England (10% of all English practices)
and Northern Ireland, capturing diagnoses, symptoms, pre-
scriptions, referrals, and tests for over 19 million patients.
Seven million patients were contributing data in 2018, which
represents 13% of the population of England (Wolf et al., 2019),
with data from Northern Ireland added in 2019. The practices
are representative of the broader population in terms of
geographical spread and deprivation (median decile on index
of multiple deprivation = 5.3), as well as age and gender. CPRD
undertakes various levels of validation and quality assurance
on the daily GP data collection, comprising over 900 checks
covering the integrity, structure, and format of its data. This
national patient database contains diagnostic codes for med-
ical conditions, including autism, stretching back over twenty
years to 1998.
Ethical considerations
The protocol was approved by the Independent Scientific
Advisory Committee (ISAC) of the Medicines and Healthcare
products Regulatory Agency (MHRA; ISAC protocol no
20_006R). Ethical approval for observational research using
the CPRD with approval from ISAC was granted by a National
Research Ethics Service committee (Trent Multi-research
Ethics Committee, REC reference No 05/MRE04/87).
Codes for autism
Diagnostic codes are recorded for each patient. Codes and
terminology used by GPs to indicate autism have changed
since the data in the CPRD were first collected in 1987. We
selected all appropriate codes used by GPs over the time period
under study, which included: infantile autism, autism, child-
hood autism, autistic disorder, atypical autism, autistic spec-
trum disorder, Asperger’s syndrome, and pervasive
developmental disorders (PDD). A comprehensive list of
included codes with number of cases in each code category is
provided in Appendix S1. The bulk of diagnoses were attrib-
uted to autism spectrum disorder (44%), autistic disorder
(10%), or simply autism (20%). 21% of all remaining diagnoses
were coded as Asperger’s syndrome; however, this code fell out
of usage after the DSM-5 was updated in 2013 to integrate it
into the autism spectrum diagnosis. All other categories
combined constituted only 6% of cases.
Validation
Previous studies have attempted to validate the autism data.
Autism data recorded during the period 1990–2014 were
validated by comparing CPRD data to the original medical
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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records of a sub-sample of patients; although the sample size
with autism was small, the positive predictive value was 91.9%
(Hagberg & Jick, 2017). An earlier validation study on GPRD
data was conducted in 2004, which had a larger sample size
and more robust methodology (Fombonne et al., 2004); cases
numbers were estimated based on a combination of an
algorithm developed to classify a range of symptoms, backed
by clinical judgment. The limitation of this approach was that
the algorithm did not require the full range of autistic behav-
iors to be present, and the diagnostic criteria themselves have
shifted since its publication. Both studies validated against
clinical records rather than population-wide assessment
specifically for autism, but together suggest that autism
diagnosis in this dataset is reasonably valid over time.
Gender was recorded for each patient according to their GP
registration form (as self-reported we consider this reflects
gender rather than sex). All cases were divided into develop-
mental age bands mirroring stages of development as laid out
in UK National Institute for Health and Care Excellence
guidance (2017): preschool and infancy (0–5 years), childhood
(6–11 years), and adolescence (12–19 years), with an extra
group to capture the trend in adult diagnosis (over 19 years).
Age of each patient at each year (1998–2018) was calculated
from the difference between year of interest and year of birth.
The numbers in each age band therefore varied at each time
point.
We generated a variable to represent broad autism (BA)
versus more severe autism (SA) by using diagnostic subcodes
as a proxy, assigning (a) Asperger’s syndrome, (b) atypical
autism, and (c) PDD-NOS as BA and (a) autistic disorder, (b)
infantile autism, (c) childhood autism, (d) Kanner’s syndrome,
and (e) PDD as SA. All other codes, the bulk of which were
simply autism or autism spectrum disorder, were classed as
‘Unknown’.
Analysis
All analyses were performed on Stata 16.
Autism incidence was defined as percentage (%) of children,
adolescents, and adults with a new record of an autism
diagnosis in each year (1998–2018). This was obtained by
dividing the number diagnosed with autism by the number of
‘acceptable’ patients in the population at each year, a method
in common with Taylor et al. (2013). The acceptable patient
metric is based on registration status, recording of events in
the patient record, and valid age and gender (Herrett et al.,
2015). All patients with acceptable data registered on 30th
June in the year of analysis were included in denominators.
Patients who had died in that year or transferred out were
included as they had the opportunity to be diagnosed. Patient
numbers in the current study were 6,786,212 in 1998 ranging
to 9,594,598 in 2018.
We assessed the incidence and how this varied between
1998 and 2018 for (a) all patients included in the analyzable
sample, (b) by age band, (c) by gender, and (d) in SA vs BA. We
used the index number to model change over time, which takes
incidence at a baseline year (1998) as 100% and tracks the
percentage increase or decrease from baseline in each subse-
quent year. Thus, if 100 people are given a diagnosis in the
baseline year, 120 in year two, and 130 in year three, the index
number will be 120 in year two, 130 in year three, and so on.
The index number captured the trend in the number of new
diagnoses given each year, not in the prevalence of autism,
which would be a cumulative figure. An index number of 102
means a 2% rise in the incidence from the base year incidence,
and an index number of 98 means a 2% fall. The index number
is often used to show time trends in economics (Office for
National Statistics, 2016).
We plotted the overall incidence index number by time (year)
and checked model fit to ascertain what shape best described
the trend. We fitted a least squares linear regression model
with year as predictor and a log transformation of the autism
index number as the outcome to ascertain the gradient, i.e.
speed of any increase. Coefficients are reported in exponenti-
ated form. The log transformation was satisfactory in over-
coming heteroscedasticity, as evidenced by both residual and
normal quantile postestimation plots.
In order to test for any moderating effects of age band in
which diagnosis occurred and gender on increasing incidence
as time passed, a multivariable regression was conducted to
test the relationship between year (predictor) and index num-
ber (rate of change in incidence by year) with gender and age
band included as well as the interaction terms between the
predictor and putative moderators (gender and age band). In
addition, the model included the interaction between gender
and age band to see whether diagnosis of females in adulthood
contributed more to the incidence pattern than in childhood.
Data sharing
This study is based on CPRD data and is subject to a full
license agreement. Electronic health records are, by definition,
considered sensitive data in the UK by the Data Protection Act
and cannot be shared via public deposition because of infor-
mation governance restrictions in place to protect patient
confidentiality. Access to data is only available once approval
has been obtained through the individual constituent entities
controlling access to the data. The primary care data can be
requested via application to the Clinical Practice Research
Datalink.
Results
By 2018, 65,665 patients had a diagnosis of autism
recorded in CPRD. Table 1 describes the patterns of
age and gender by year for those with or without
diagnosis of autism for each birth year. These show,
as expected, a higher proportion of males than
females in the sample with an autism diagnosis at
baseline (81.6% were male in 1998), with a much
larger proportion of patients assigned a diagnosis in
younger age bands (in 1998, 91.4% of patients
assigned an autism diagnosis were aged 19 years
or younger, and 80.6% were under 12).
Incidence of autism
The overall time trend of new cases of autism
diagnosis by year is illustrated in Figure 1. The
figure, in contrast to Table 1, plots the trend in
increasing incidence of new diagnoses, as a percent-
age increase from 100% modeled at baseline year in
1998: the index number. The figure starkly illus-
trates an overall 787% increase in recorded inci-
dence of autism diagnosis over 20 years. The
exponential model (log transformed outcome) was a
very good fit to the data; R2 = 0.98, exponentiated
coefficient = 1.07, 95% CI [1.06, 1.08], p < .001.
The mean age of diagnosis rose, not only in the
dataset as a whole, from a mean age of 9.6 years
(SD = 9.4) in 1998 to 14.5 years (SD = 12.7) in 2018,
but also rose within every specific age band
(Table S1). Median and modal age of diagnosis also
increased during the twenty-year period, although
there was no change within the infant and preschool
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groups: median and modal age for those diagnosed
in infancy remained 2 years for the entire 20-year
period. The mean age at which males received a
diagnosis across the whole dataset was 12.3 years
old (SD = 11.5) and for females 14.9 years old
(SD = 12.4). With the exception of one year in the
20-year period, within each year, the average age of
diagnosis for females was greater than for males
(Table S1).
Figure 2(i) illustrates the increases in rates of
autism diagnosis by developmental stage. The
increasing incidence of diagnosis was greater for
adults and older children than for younger children.
Compared with the youngest age band (0–5 years),
being in an older age band strengthened the expo-
nential relationship between year and increasing
incidence of autism diagnosis (Table 2). One adult
per 100,000 was diagnosed in 1998, versus twenty
in 2018. Note the baseline in 1998 is held at the
same level for all four groups; in reality, there were
far more children and adolescents diagnosed year on
year than adults.
Table 1 Demographic characteristics of patients with and without a diagnosis of autism, 1998 to 2018
Year






















1998 3,072 81.67 57.10 23.50 10.77 8.63 6,785,544 49.87 5.96 6.61 7.75 79.68
1999 3,948 82.09 53.95 25.08 11.88 9.09 7,023,959 49.94 5.89 6.57 7.85 79.69
2000 5,043 82.31 50.35 27.17 12.91 9.58 7,197,770 50.02 5.85 6.52 7.96 79.67
2001 6,290 82.51 47.63 28.33 14.01 10.03 7,366,131 50.08 5.86 6.43 8.09 79.63
2002 7,812 82.73 44.75 29.56 15.17 10.52 7,545,217 50.11 5.84 6.32 8.20 79.63
2003 9,488 82.62 42.51 30.60 15.74 11.16 7,702,452 50.14 5.86 6.24 8.31 79.59
2004 11,326 82.78 40.38 32.04 16.29 11.29 7,832,871 50.18 5.92 6.18 8.39 79.51
2005 13,158 82.73 38.89 32.75 16.93 11.43 7,935,910 50.17 6.01 6.16 8.40 79.43
2006 15,230 82.67 37.44 33.62 17.26 11.67 8,074,625 50.15 6.10 6.15 8.41 79.34
2007 17,353 82.80 36.24 34.34 17.75 11.67 8,211,364 50.10 6.18 6.19 8.34 79.29
2008 19,604 82.77 35.26 34.71 18.18 11.84 8,349,711 50.07 6.32 6.21 8.28 79.19
2009 22,217 82.62 34.47 35.06 18.49 11.98 8,453,071 50.03 6.41 6.30 8.21 79.08
2010 25,101 82.35 33.53 35.17 18.97 12.33 8,577,288 50.01 6.46 6.37 8.14 79.03
2011 28,302 82.01 32.72 35.19 19.41 12.68 8,665,355 49.88 6.55 6.46 8.13 78.85
2012 31,858 81.76 32.09 35.25 19.64 13.02 8,794,391 49.82 6.58 6.55 8.13 78.74
2013 36,022 81.27 31.54 34.94 19.89 13.63 8,733,804 49.77 6.69 6.76 8.18 78.37
2014 40,479 80.71 30.81 34.84 20.14 14.21 8,821,168 49.83 6.64 6.94 8.24 78.18
2015 45,462 80.07 30.23 34.58 20.32 14.86 8,986,878 49.81 6.53 7.02 8.38 78.06
2016 51,484 79.35 29.36 34.62 20.67 15.35 9,165,230 49.80 6.41 7.07 8.51 78.02
2017 58,224 78.48 28.58 34.69 21.04 15.69 9,358,837 49.78 6.26 7.10 8.62 78.02
2018 65,665 77.49 27.83 34.50 21.50 16.17 9,531,337 49.80 6.07 7.10 8.74 78.09
This table shows cumulative prevalence, taking into account diagnoses made prior to 1998.
Figure 1 Percentage increase in incidence of autism diagnosis from 1998 to 2018
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Figure 2(ii) illustrates the relative pace of increase
in diagnosis of males compared with females. Gen-
der was a significant moderator of the increase in
incidence over time; female gender predicted a bigger
increase in incidence (exponentiated coefficient =
1.02, 95% CI [1.01, 1.03], p < .001). The gradient of
growth in diagnosis for females has been, on aver-
age, increasing by more per year than that for males.
The breakdown of plots of percentage increase in
diagnosis over time by gender and age band is given
in Figure S1 and shows the pattern of rising diag-
nosis by gender at each age band. Being female was
associated with increasing levels of diagnosis at
adolescence compared with preschool. However, this
was not the case in adulthood, where there was no
gender difference (see Table 2).
The comparative time trend between those classed
with SA and BA is shown in Figure 3. BA diagnoses
increased more than SA up until 2013, when DSM-5
revisions led to recommendations to drop the diag-
nostic subcodes used to code BA and SA.
Discussion
The overall increase in incidence of diagnosis of
autism is consistent with other reports from the
United States and Europe (Boyle et al., 2011; Keyes
et al., 2012; Maenner & Durkin, 2010; Parner et al.,
2008; Smeeth et al., 2004). Previously, analysis of
the GPRD between 2004 and 2010 for children age 8
indicated the incidence was stable (Taylor et al.,
2013). Similarly, we found the number of incident
cases in children age 8 remained stable from 2005
right through to 2009, but it did increase in 2010.
This discrepancy may be because Taylor et al.
excluded data from GP practices contributing data
 (i) : Percentage increase in incidence of autism diagnosis from 1998 to 2018 by age-
band. 
(ii): By gender. 
Figure 2 (i) Percentage increase in incidence of autism diagnosis from 1998 to 2018 by age band. (ii) By gender
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
Time trends in autism diagnosis 5
after 1996, which we did not. Our current findings,
taken over a longer period and with multiple age
groups, indicate the overall trend is actually one of
the increasing application of diagnosis over time.
The finding that increases in incidence of diagno-
sis were greater in adults and females suggests
changes in identification and recording of autism
diagnosis in these new cohorts (females, adults) as at
least one contributor to these changes. There have
been concerted campaigns to raise awareness of
autism in both these groups, while there is no clear
etiological explanation for why more adults and
females might be developing autism compared with
children and males.
The increase in age of diagnosis with time may be
due to an increase in demand for assessment arising
from greater public awareness of autism, combined
with recent cuts to children’s assessment services:
diagnostic services risk being swamped. In 2020,
NHS wait times from referral to diagnosis were
reported as 352 days (1 year) for under 18s (NHS
Digital, 2021), albeit services were hampered by the
pandemic. Increased age of diagnosis in preschool
age bands could be partly because diagnosis of
autism in younger children is obviously complex and
may need to go at the family’s pace. De-
stigmatization of the label due to work by the
neurodiversity movement and parent-led lobby
groups may have contributed to rising demand for
diagnosis in order to access support, in turn leading
to changes in clinical practice. The inclusion of more
cognitively able/BA individuals in the expanding
spectrum (Keyes et al., 2012) has contributed to
longer waiting lists as time has passed. As a larger
proportion of cognitively able individuals are diag-
nosed with autism, the average age of diagnosis
within each developmental stage may increase, as
they do not present the immediate and complex
needs of classic infantile autism and therefore tend
to be referred and identified later (Hertz-Picciotto &
Delwiche, 2009).
Trends in age bands
Many texts and guidelines argue that the earlier
diagnosis is made the better, so children can receive
early intervention before critical developmental
stages elapse (e.g., language acquisition). Reports
show decreases in the mean and median ages at
which childhood autism diagnoses are made in
California (King, Fountain, Dakhlallah, & Bearman,
2009) and Denmark (Parner et al., 2008), yet we
found the opposite, suggesting that the stated policy
goal of earlier recognition is not being achieved.
Adults were an under-recognized group in the UK
and lobbying successfully led to implementation of
the Autism Act. Similar legislation has recently
extended to children, and it remains to be seen
whether the age of diagnosis subsequently
decreases. Our finding of a marked increase in adult
diagnoses compared with other age bands, which
accelerated after 2009 when UK adult autism diag-
nostic assessment services were made statutory,
suggests the new adult diagnostic assessment ser-
vices are having an impact. However, wait times for
assessment can be long. If private care is being
utilized to avoid waiting for diagnosis, the actual
increase in diagnosis may be even higher, since such
diagnoses may not be fed back to GPs.
Trend by gender
A meta-analysis of over 50,000 participants with
autism showed that in population-based studies of




Age band (Preschool = reference)
Childhood 1.03 1.01 1.05 <.001
Adolescence 1.04 1.04 1.05 <.001
Adulthood 1.06 1.05 1.07 <.001
Preschool 9 Gender (Reference)
Childhood 9 Gender 1.01 1.00 1.03 .321
Adolescence 9 Gender 1.03 1.01 1.05 .002
Adulthood 9 Gender 1.00 0.98 1.02 .665











1995 2000 2005 2010 2015 2020
BA SA
Figure 3 Percentage increase in incidence of autism diagnosis
from 1998 to 2018 by diagnostic codes
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people with autism there are three males to every
female, whereas in clinic-based samples the ratio is
nearer four to one (Loomes et al., 2017). This
suggests that females with autism are less often
identified and diagnosed. Some researchers suggest
this is possibly because they are better able to mask
autistic difficulties (Hull et al., 2017). Others pro-
pose that the behavioral characteristics of autism
may be different in females compared with males,
while the diagnostic criteria are based on symptoms
seen in males (Kirkovski, Enticott, & Fitzgerald,
2013). Autism is popularly conceptualized as a
‘male’ disorder. Such understandings may have led
to gender stereotyping by education professionals,
clinicians, and parents when identifying children
with severe symptoms. In response to these research
narratives, there has been a drive toward referral of
more females. Our findings, showing a marked
growth in female diagnoses compared with males,
suggest such initiatives have been having an effect. If
girls tend to be missed, we would expect perhaps to
see a steeper rate of female diagnoses in older age
bands compared with early childhood, and this was
true in adolescence but not in adulthood. However,
females were on average diagnosed at older ages
than males at almost every time point (Table 1)
which does support this interpretation.
In their review of sex and gender differences, Lai
and Szatmari (2020) found diagnosed females
showed fewer restricted/repetitive behaviors/inter-
ests/activities and were more likely to have better
cognitive development, less intense autistic symp-
toms and displayed a greater reduction in symptoms
over time than males. Despite this, their review
suggests females may experience more challenges at
adolescence than males, perhaps prompting the
need for a diagnosis, which might partly explain
the observed disproportionate rise in female diagno-
sis at adolescence. Intriguingly, Figure S1 indicates
a steeper increase in female diagnosis at adulthood
in the last two years of the time trend. Future
research could determine whether this pattern is
sustained.
Trend by SA/BA
The pattern of SA/BA diagnosis (Figure 3) was as
expected: the rate of broad autism (BA) diagnosis,
mostly accounted for by our coding of Asperger’s
included in BA, increased more than SA up until
2013. The subsequent drop-off is very likely due to the
reduction in ongoing use of ‘Asperger’s’ and ‘autistic
disorder’ as distinct labels after 2013 DSM-5 revisions
came into effect, replacing these codes with the more
generic ‘autism spectrum disorder’ and ‘autism’,
which accounted for a growing majority of the increas-
ing incidence of diagnosis after 2013. The picture
given in Figure 3 is revealing, yet is limited by the
many missing cases as only around a third of all cases
in CPRD could be classified as SA or BA. The figure
broadly suggests a larger part of the rise in diagnosis
rates in the UK was attributable to diagnosis of
individuals without severe autism, up until 2013.
After this timepoint, it was not possible to distinguish
by diagnostic subcodes, although the trend may well
have continued. Given the limits imposed by missing
data and that actually the bulk of diagnoses cannot be
attributed to SA or BA, combined with issues about
changes to diagnostic codes that were applied given
changing DSM criteria, we decided not to formally test
the BA/SA comparison.
As autistic traits are normally distributed (Steer,
Golding, & Bolton, 2010), and the observed trend is
one of the diagnosing cases with more typical cogni-
tive ability or less severe traits over time (Arvidsson
et al., 2018), a small shift in the cutoff threshold for
diagnosis could lead to a relatively large increase in
the number of cases, as there are simply more
individuals nearer the population mean than at the
severe end of the spectrum. This may contribute to
the exponential pattern observed.
Strengths and weaknesses of the study
The main strength of this analysis is the extensive
and large dataset, broadly representative of the UK
population that avoids the biases of specialist clinic-
based studies. However, the database has inherent
limitations around data completeness. Although
validation studies show what data there are are of
good quality (a recent study reported 91.9% positive
predictive value for autism codes in the CPRD;
Hagberg & Jick, 2017), there is likely missing data
due to private diagnoses and incomplete recording in
primary care. The patient groups missing from
primary care records include prisoners, private
patients, some residential homes, and the homeless.
Linkage of mental health data from Child and
Adolescent Mental Health services would not
improve our ability to compare time trends because
the routine data available are patchy: data from
some services are not submitted or are incomplete,
and other pathways, such as community pediatrics
and diagnoses, are often made in private clinics in
the UK, which are not included in the data.
Because of this potential for missing data, we
chose not to concentrate on absolute incidence or
prevalence rates, rather keeping the analysis
focused on a comparative trend in diagnosis over
time. Whether autism is actually recognized, that is,
diagnosed in the first place, is a distinct issue that
could also lead to underestimates of population
prevalence when using GP data. We therefore argue
against publishing UK autism prevalence estimates
based on GP data, which could be misleading.
Instead, we advocate caution (not reporting absolute
point prevalence estimates due to possibility of
missing cases in clinical records) and a comparative
approach (covering all age ranges) showing patterns
and trends in identification.
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
Time trends in autism diagnosis 7
Our analysis suggests the makeup of the diag-
nosed autistic population is shifting along with the
increasing incidence. There are now larger propor-
tions of females and adults in the UK population with
an autism diagnosis and, until DSM-5 revised the
codes, our subcode analysis indicated an increasing
proportion of diagnoses of broad, less severe autism.
We suspect that this is an artefactual change (a shift
in who is considered to have autism). Our finding
that different groups have shown different rates of
increase is consistent with this interpretation. How-
ever, we cannot discount the possibility of accompa-
nying ‘real’ increases, that is, more individuals
having symptoms of autism as time has passed.
Narratives about diagnosis are likely to be further
reinforced by clinical recognition and identification
itself. As more females, for example, are diagnosed,
there are more women identified with autism who
make a vocal contribution about how theymissed out
on diagnosis when younger, and more females with
autismare talked about and seen, thereby reinforcing
narratives about female autism and spurring further
research and clinical recognition. Thus, the rise fuels
the rise, in the sense that themore often a diagnosis is
applied, the more people rally around its banner and
advocate formore diagnosis (Russell, 2020).
Our findings need replication in other datasets,
particularly those linked between primary and sec-
ondary care. Further research could usefully examine
the influence of factors that may affect accessibility to
diagnosis (e.g., rurality), as well as socioeconomic
status or ethnicity as these were associated with
autism in England in an analysis of educational
records (Roman-Urrestarazu et al., 2021). Additional
research is also required to establish whether diag-
nosis is followed by any support, which data linkage
might allow researchers to explore.
Supporting information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article:
Appendix S1. List of available codes categorized as
‘autism’.
Table S1. Mean and SD age of diagnosis by year of
recording.
Figure S1. Percentage increase in incidence of autism
diagnosis from 1998 to 2018 by gender at each age
band.
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Key points
 Previous UK studies have conflicting findings as to whether rates of autism diagnosis are increasing.
 Ours is first study to analyze the time trend of autism diagnosis in a population-based UK clinical cohort by
developmental stage, level of severity and by gender, over a twenty-year period.
 Results show an exponential increase in use of autism diagnosis over time.
 New subpopulations previously seldom considered for autism diagnosis (females, adults) have steepest
growth in diagnosis rates.
 Differing rates of increase between subgroups suggest effects are primarily due to increased recognition,
although an actual increase in autism incidence cannot be ruled out.
 2009 UK policy to invest in adult assessment centers may underpin rise in adult diagnosis.
 Rising age at diagnosis in infancy and childhood suggests policy to improve early recognition of autism has
had limited effect.
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